Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Notice for human papillomavirus 9-valent vaccine (Merck Sharp & Dohme (Australia) Pty Ltd)
Active ingredients
human papillomavirus 9-valent vaccine
Date of review outcome
Lapse date
Type
Provisional approval
Therapeutic area
Infectious diseases